iVIEW Therapeutics collaborates with Ophthalmology Department of Zhongshan Eye Hospital of Fudan University in Shanghai on the iVIEW-1201 phase II trials for the treatment of viral conjunctivitis

[April 26, 2018, Shanghai] Dr. Bo Liang, Chairman of iVIEW Therapeutics Inc., came to Zhongshan Eye Hospital, Shanghai to talk with Professor Fei Yuan, Chief Physician of Ophthalmology at Zhongshan Eye Hospital of Fudan University, about the collaboration for iVIEW-1201 project clinical trials in China for the treatment of viral conjunctivitis.

The Department of Ophthalmology, Zhongshan Eye Hospital, was founded in 1945 and rebuilt in 1976. The Department inherits a fine tradition and has clear advantages. It has established outstanding development in areas such as adjustable, multifocal intraocular lens implantation and phakic intraocular lens implantation, as well as clinical epidemiology. It has built up excellent academic influence in China and internationally. A large number of research papers have been resulted in original researches conducted in the hospital and published in reputable international journals.

iVIEW Therapeutics Inc. has a built up a top-notch team composed of pharmaceutical industry experts and ophthalmologists dedicating to the development of innovative drugs targeting unmet medical needs in the areas of ophthalmology and rhinology,
Dr. Liang and Prof. Fei Yuan conducted in-depth exchanges and discussions about the clinical trial plans in China and clinical trial development collaboration was established.

This collaboration with the Department of Ophthalmology, Zhongshan Eye Hospital marks another milestone of the iVIEW-1201 clinical development program at iVIEW Therapeutics Inc.

Pennsylvania Biotechnology Center at Bucks County
3805 Old Easton Road
Doylestown PA 18902 USA
Copyright © 2019 iVIEW Therapeutics, Inc. All rights reserved.